BioPharm International-09-01-2013

BioPharm International

Trends in Downstream Bioprocessing

September 01, 2013

Separation and Purification

26

9

While the severity of capacity problems related to downstream processing appears to have eased, it continues to be a problem and chromatography columns are the most frequent culprits.

Regulatory Roundup

September 01, 2013

Regulatory Beat

26

9

Updates on user fees, heparin supply concerns, orphan drug incentives, REMS updates, reference standards for proteins, and patent settlements.

Gauging the Outlook of the Biologics Market

September 01, 2013

Special Section

26

9

Mike Jenkins, general manager of Catalent Biologics discusses the evolving landscape of the biologics market and hurdles faced in the development and manufacture of these innovative products.

Connecting People, Science, and Regulation

September 01, 2013

Guest Editorial

26

9

PDA/FDA regulatory conference promotes a commitment to quality.

BioPharm International, September 2013 Issue (PDF)

September 01, 2013

Issue PDF

26

9

Click the title above to open the BioPharm International September 2013 issue in an interactive PDF format.

BioPharm International, September 2012 Issue (PDF)

September 01, 2012

Issue PDF

26

9

Trends in BioPharma